These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29016878)

  • 1. Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial.
    Varma N; Love CJ; Schweikert R; Moll P; Michalski J; Epstein AE;
    Europace; 2018 Apr; 20(4):622-628. PubMed ID: 29016878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
    Varma N; Michalski J; Epstein AE; Schweikert R
    Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):428-36. PubMed ID: 20716717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
    Varma N
    Am Heart J; 2007 Dec; 154(6):1029-34. PubMed ID: 18035071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations.
    Varma N; Michalski J; Stambler B; Pavri BB;
    Eur Heart J; 2014 May; 35(20):1345-52. PubMed ID: 24595864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.
    Pedersen SS; Skovbakke SJ; Wiil UK; Schmidt T; dePont Christensen R; Brandt CJ; Sørensen J; Vinther M; Larroudé CE; Melchior TM; Riahi S; Smolderen KGE; Spertus JA; Johansen JB; Nielsen JC
    BMC Cardiovasc Disord; 2018 Jul; 18(1):136. PubMed ID: 29969990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
    Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
    Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry.
    Ricci RP; Morichelli L; D'Onofrio A; Calò L; Vaccari D; Zanotto G; Curnis A; Buja G; Rovai N; Gargaro A
    Europace; 2013 Jul; 15(7):970-7. PubMed ID: 23362021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of daily remote monitoring on pacemaker longevity: a retrospective analysis.
    Ricci RP; Morichelli L; Quarta L; Porfili A; Magris B; Giovene L; Torcinaro S; Gargaro A
    Heart Rhythm; 2015 Feb; 12(2):330-7. PubMed ID: 25444853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact).
    Hansen C; Loges C; Seidl K; Eberhardt F; Tröster H; Petrov K; Grönefeld G; Bramlage P; Birkenhauer F; Weiss C
    BMC Cardiovasc Disord; 2018 Jun; 18(1):131. PubMed ID: 29954340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
    Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
    Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study.
    Guédon-Moreau L; Lacroix D; Sadoul N; Clémenty J; Kouakam C; Hermida JS; Aliot E; Kacet S;
    Europace; 2014 Aug; 16(8):1181-8. PubMed ID: 24614572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems.
    Varma N; Pavri BB; Stambler B; Michalski J;
    Europace; 2013 May; 15(5):697-703. PubMed ID: 23258817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.
    Varma N; Epstein AE; Schweikert R; Michalski J; Love CJ;
    J Cardiovasc Electrophysiol; 2016 Mar; 27(3):321-6. PubMed ID: 26661687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life.
    Merchant FM; Jones P; Wehrenberg S; Lloyd MS; Saxon LA
    J Am Heart Assoc; 2014 Nov; 3(6):e001289. PubMed ID: 25385346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.
    Doppalapudi H; Barrios J; Cuellar J; Gannon M; Yamada T; Kumar V; Maddox WR; Plumb VJ; Brown TM; McElderry HT
    J Cardiovasc Electrophysiol; 2017 May; 28(5):552-558. PubMed ID: 28181727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic implantable cardioverter-defibrillator: patient survival, battery longevity and shock delivery analysis.
    Gabry MD; Brodman R; Johnston D; Frame R; Kim SG; Waspe LE; Fisher JD; Furman S
    J Am Coll Cardiol; 1987 Jun; 9(6):1349-56. PubMed ID: 3584723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.